159 related articles for article (PubMed ID: 35232339)
1. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
2. Autokinase Activity of Casein Kinase 1 δ/ε Governs the Period of Mammalian Circadian Rhythms.
Guo G; Wang K; Hu SS; Tian T; Liu P; Mori T; Chen P; Johnson CH; Qin X
J Biol Rhythms; 2019 Oct; 34(5):482-496. PubMed ID: 31392916
[TBL] [Abstract][Full Text] [Related]
3. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
[TBL] [Abstract][Full Text] [Related]
4. CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation.
Ko VI; Ong K; Cleveland DW; Yu H; Ravits JM
Neurobiol Dis; 2024 Jun; 196():106516. PubMed ID: 38677657
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
Li SS; Dong YH; Liu ZP
Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
[TBL] [Abstract][Full Text] [Related]
6. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
7. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.
Meng QJ; Maywood ES; Bechtold DA; Lu WQ; Li J; Gibbs JE; Dupré SM; Chesham JE; Rajamohan F; Knafels J; Sneed B; Zawadzke LE; Ohren JF; Walton KM; Wager TT; Hastings MH; Loudon AS
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15240-5. PubMed ID: 20696890
[TBL] [Abstract][Full Text] [Related]
8. Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.
Calenda S; Catarzi D; Varano F; Vigiani E; Volpini R; Lambertucci C; Spinaci A; Trevisan L; Grieco I; Federico S; Spalluto G; Novello G; Salmaso V; Moro S; Colotta V
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675428
[TBL] [Abstract][Full Text] [Related]
9. Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2.
Eng GWL; Edison ; Virshup DM
PLoS One; 2017; 12(5):e0177834. PubMed ID: 28545154
[TBL] [Abstract][Full Text] [Related]
10. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε.
Yang Y; Xu T; Zhang Y; Qin X
Cell Signal; 2017 Feb; 31():58-65. PubMed ID: 28057520
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration.
Kishino Y; Matsukawa K; Matsumoto T; Miyazaki R; Wakabayashi T; Nonaka T; Kametani F; Hasegawa M; Hashimoto T; Iwatsubo T
J Biol Chem; 2022 Aug; 298(8):102191. PubMed ID: 35753345
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ.
Choi JY; Noguchi Y; Alburger JM; Bayle S; Chung E; Grant W; Chaikuad A; Knapp S; Duckett DR; Roush WR
J Med Chem; 2023 Jun; 66(11):7162-7178. PubMed ID: 37204207
[TBL] [Abstract][Full Text] [Related]
14. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
15. Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A).
Wolff S; Xiao Z; Wittau M; Süssner N; Stöter M; Knippschild U
Biochim Biophys Acta; 2005 Sep; 1745(2):196-206. PubMed ID: 15961172
[TBL] [Abstract][Full Text] [Related]
16. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development.
Knippschild U; Wolff S; Giamas G; Brockschmidt C; Wittau M; Würl PU; Eismann T; Stöter M
Onkologie; 2005 Oct; 28(10):508-14. PubMed ID: 16186692
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
18. Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).
Xu P; Ianes C; Gärtner F; Liu C; Burster T; Bakulev V; Rachidi N; Knippschild U; Bischof J
Gene; 2019 Oct; 715():144005. PubMed ID: 31376410
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
[TBL] [Abstract][Full Text] [Related]
20. Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A
Francucci B; Angeloni S; Dal Ben D; Lambertucci C; Ricciutelli M; Spinaci A; Smirnov A; Volpini R; Buccioni M; Marucci G
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
